Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
Key Takeaway Complete overview of CJC-1295/Ipamorelin side effects including water retention, tingling, fatigue, and what clinical data shows about safety and tolerability
Peptide Vials (Injectable) Math anchored to 50 mg vials at 25 mg/mL after 2.0 mL reconstitution
doi: 10.1016/j.immuni.2010.03.012 [DOI] [PubMed] [Google Scholar] 104
Rights and permissions About this article Cite this article Lundberg, J., Gladwin, M
The formula can be customized to include B12, biotin, amino acids, and other growth-stimulating components